Systemic barriers to recruitment of blood donors from African, Caribbean, and Black communities.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow\u2010up

Spatial and multi\u2010omic profiling reveals pericyte\u2010derived CCL19 as a key prognostic factor in CNS lymphoma

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high\u2010sensitivity detection of ctDNA by next\u2010generation sequencing

CAR T\u2010cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma

Complementary efficacy of CD127\u2010directed immunotherapy with lusvertikimab and ABL\u2010targeting tyrosine kinase inhibitors in preclinical ABL\u2010class\u2010fusion\u2010positive B\u2010ALL

Systemic barriers to recruitment of blood donors from African, Caribbean, and Black communities.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow\u2010up

Spatial and multi\u2010omic profiling reveals pericyte\u2010derived CCL19 as a key prognostic factor in CNS lymphoma

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high\u2010sensitivity detection of ctDNA by next\u2010generation sequencing

CAR T\u2010cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma

Complementary efficacy of CD127\u2010directed immunotherapy with lusvertikimab and ABL\u2010targeting tyrosine kinase inhibitors in preclinical ABL\u2010class\u2010fusion\u2010positive B\u2010ALL